BASKING RIDGE, N.J., Oct. 26-- Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation ...
ALK, a global specialty pharmaceutical company, presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, ...
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする